RxDoctor Payments Data

Todd Bullock

Family · Caneyville, KYNPI 1104822360

Payments from drug & device makers

$1,335in general payments, 2019–2025

Across 87 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$208
  • Pfizer$175
  • Merck$130
  • Lilly USA, LLC$107
  • AstraZeneca$107
  • GSK$91
  • plus $518 from 20 others

What the payments were for

  • Food & beverage$1,32499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,335 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin232$175,946
EliquisApixaban134$96,419
Tresiba Flextouch U-200Insulin Degludec61$58,655
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$57,323
MounjaroTirzepatide40$49,893
JanuviaSitagliptin Phosphate43$48,001
OzempicSemaglutide34$38,393
FarxigaDapagliflozin Propanediol47$37,117
TrulicityDulaglutide35$33,926
Wellbutrin XlBupropion Hcl13$33,424
XareltoRivaroxaban48$32,035
Breo ElliptaFluticasone/Vilanterol64$26,481
Tresiba Flextouch U-100Insulin Degludec32$22,648
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$21,438
VraylarCariprazine Hcl13$17,791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$19$191,381262 claims
PfizerEliquis$175$96,419134 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$91$95,533153 claims
Lilly USA, LLCMounjaro, Trulicity$107$83,81975 claims
MerckJanuvia, Steglatro, Janumet$130$63,21268 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$107$56,33584 claims
Novo NordiskOzempic, Novolog$208$40,94757 claims
Johnson & JohnsonXarelto$31$32,03548 claims
AbbVieVraylar, Linzess, Synthroid$80$30,32583 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Caneyville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →